Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2020/5892047 http://scihub22266oqcxt.onion/10.1155/2020/5892047 32802540!7415102!32802540     free     free     free       Case+Rep+Otolaryngol 2020 ; 2020 (?): 5892047 Nephropedia Template TP {{tp|p=32802540|t=2020. Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient |pdf=|usr=}}{{32802540}} gab.com Text Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient JO: Case Rep Otolaryngol http://www.kidney.de/pget.php?&tw=1&pmid=32802540 #FOAvip Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19. Twit Text FOAVip Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient ????Case Rep Otolaryngol http://www.kidney.de/pget.php?&tw=1&pmid=32802540 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32802540 #FOAvip English Wikipedia <ref>{{Cite pmid|32802540}}</ref> Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient #MMPMID32802540 Touisserkani SK; Ayatollahi A Case Rep Otolaryngol 2020[]; 2020 (?): 5892047 PMID32802540show ga Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19. ?Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Pa(epmc).pdf DeepDyve Pubget Overpricing